AKT1 and acute myeloid leukemia: Here we demonstrate that TIMP-1 increases the clonogenic efficiency, the survival and the migratory capacity of AML blasts by binding to CD63 receptor which, in turn, results in the activation of PI3K, Akt phosphorylation and regulation of downstream targets, such as p21 and HIF-1α.